本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Assembly Biosciences Inc.

29.80
-0.6600-2.17%
盤後29.800.00000.00%19:30 EDT
成交量:25.89萬
成交額:779.56萬
市值:6.07億
市盈率:-1.16萬
高:31.72
開:30.83
低:29.68
收:30.46
52周最高:39.71
52周最低:20.23
股本:2,036.06萬
流通股本:917.37萬
量比:0.77
換手率:2.82%
股息:- -
股息率:- -
每股收益(TTM):-0.0026
每股收益(LYR):-0.5461
淨資產收益率:-0.03%
總資產收益率:-2.67%
市淨率:1.99
市盈率(LYR):-54.57

資料載入中...

2021/02/25

重要事件披露

8-K - Current report
2021/02/17

重要事件披露

8-K - Current report
2021/02/17

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/10

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/09

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/29

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/27

重要事件披露

8-K - Current report
2021/01/12

SEC問詢函

CORRESP [Cover] - Correspondence
2021/01/04

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/12/08

重要事件披露

8-K - Current report
2020/11/17

重要事件披露

8-K - Current report
2020/11/05

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/11/05

重要事件披露

8-K - Current report
2020/10/21

重要事件披露

8-K - Current report
2020/09/03

SEC問詢函

CORRESP [Cover] - Correspondence